Biologics: Targets and Therapy
Volume 18, 2024 - Issue
Open access
189
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Wu Lin1 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, People’s Republic of ChinaView further author information
, Yuxiang Yan2 Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, People’s Republic of ChinaView further author information
, Qingling Huang1 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, People’s Republic of ChinaView further author information
& Dali Zheng2 Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-2345-4040View further author information
https://orcid.org/0000-0003-2345-4040View further author information
Pages 61-78
|
Received 15 Sep 2023, Accepted 08 Dec 2023, Published online: 31 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.